ACOG Committee Opinion No. 458: Hysterosalpingography after tubal sterilization.
The U.S. Food and Drug Administration has approved two devices for hysteroscopic tubal sterilization. To minimize the failure rates of these effective methods, it is important for health care providers to understand the important role hysterosalpingography (HSG) plays in any hysteroscopic tubal sterilization procedure. The purpose of this Committee Opinion is to emphasize the necessity of performing HSG 3 months after hysteroscopic tubal sterilization and to identify factors that may interfere with performance of an adequate HSG assessment.
D000075202:Contraindications; D055356:Endometrial Ablation Techniques; D019544:Equipment Failure Analysis; D005260:Female; D006801:Humans; D007047:Hysterosalpingography; D019736:Prostheses and Implants; D013246:Sterilization, Tubal / Q000295:instrumentation*